Literature DB >> 21710380

Fragment-based approaches and computer-aided drug discovery.

Didier Rognan1.   

Abstract

Fragment-based design has significantly modified drug discovery strategies and paradigms in the last decade. Besides technological advances and novel therapeutic avenues, one of the most significant changes brought by this new discipline has occurred in the minds of drug designers. Fragment-based approaches have markedly impacted rational computer-aided design both in method development and in applications. The present review illustrates the importance of molecular fragments in many aspects of rational ligand design, and discusses how thinking in "fragment space" has boosted computational biology and chemistry.

Mesh:

Substances:

Year:  2012        PMID: 21710380     DOI: 10.1007/128_2011_182

Source DB:  PubMed          Journal:  Top Curr Chem        ISSN: 0340-1022


  7 in total

1.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.

Authors:  Chris de Graaf; Albert J Kooistra; Henry F Vischer; Vsevolod Katritch; Martien Kuijer; Mitsunori Shiroishi; So Iwata; Tatsuro Shimamura; Raymond C Stevens; Iwan J P de Esch; Rob Leurs
Journal:  J Med Chem       Date:  2011-11-07       Impact factor: 7.446

2.  Fragment-based strategy for structural optimization in combination with 3D-QSAR.

Authors:  Haoliang Yuan; Wenting Tai; Shihe Hu; Haichun Liu; Yanmin Zhang; Sihui Yao; Ting Ran; Shuai Lu; Zhipeng Ke; Xiao Xiong; Jinxing Xu; Yadong Chen; Tao Lu
Journal:  J Comput Aided Mol Des       Date:  2013-11-01       Impact factor: 3.686

3.  HTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes.

Authors:  Carlo Baggio; Linda Cerofolini; Marco Fragai; Claudio Luchinat; Maurizio Pellecchia
Journal:  ACS Med Chem Lett       Date:  2018-01-17       Impact factor: 4.345

4.  PyPLIF HIPPOS-Assisted Prediction of Molecular Determinants of Ligand Binding to Receptors.

Authors:  Enade P Istyastono; Nunung Yuniarti; Vivitri D Prasasty; Sudi Mungkasi
Journal:  Molecules       Date:  2021-04-22       Impact factor: 4.411

5.  Structure-based design of eugenol analogs as potential estrogen receptor antagonists.

Authors:  Yulia Anita; Muhammad Radifar; Leonardus Bs Kardono; Muhammad Hanafi; Enade P Istyastono
Journal:  Bioinformation       Date:  2012-10-01

6.  Prioritizing target-disease associations with novel safety and efficacy scoring methods.

Authors:  Mario Failli; Jussi Paananen; Vittorio Fortino
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

7.  Perspectives on High-Throughput Ligand/Protein Docking With Martini MD Simulations.

Authors:  Paulo C T Souza; Vittorio Limongelli; Sangwook Wu; Siewert J Marrink; Luca Monticelli
Journal:  Front Mol Biosci       Date:  2021-03-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.